Found: 143
Select item for more details and to access through your institution.
The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Therapeutic potential of antisense oligodeoxynucleotides in downregulating p53 oncogenic mutations in cancers.
- Published in:
- Biotechnology Letters, 2011, v. 33, n. 2, p. 221, doi. 10.1007/s10529-010-0423-5
- By:
- Publication type:
- Article
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 4199, doi. 10.1007/s10238-023-01189-9
- By:
- Publication type:
- Article
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 751, doi. 10.1002/ajh.23731
- By:
- Publication type:
- Article
Unusual case of metachronous EBV-associated B-cell and NK/T-cell lymphoma mimicking polymyositis-diagnostic challenges and pitfalls.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 1, p. 110, doi. 10.1002/ajh.23572
- By:
- Publication type:
- Article
Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 663, doi. 10.1002/ajh.23213
- By:
- Publication type:
- Article
Immunoglobulin M Monoclonal Gammopathies of Clinical Significance.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.905484
- By:
- Publication type:
- Article
Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.880923
- By:
- Publication type:
- Article
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 453, p. 1, doi. 10.1126/scitranslmed.aan0941
- By:
- Publication type:
- Article
Tumor-Associated Macrophages and Related Myelomonocytic Cells in the Tumor Microenvironment of Multiple Myeloma.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5654, doi. 10.3390/cancers14225654
- By:
- Publication type:
- Article
Metabolic Vulnerabilities in Multiple Myeloma.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1905, doi. 10.3390/cancers14081905
- By:
- Publication type:
- Article
Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5147, doi. 10.3390/cancers13205147
- By:
- Publication type:
- Article
Microenvironmental Hypoxia Induces Dynamic Changes in Lung Cancer Synthesis and Secretion of Extracellular Vesicles.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2917, doi. 10.3390/cancers12102917
- By:
- Publication type:
- Article
Targeting NF-κB Signaling for Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2203, doi. 10.3390/cancers12082203
- By:
- Publication type:
- Article
Natural History and Prognostic Factors at First Relapse in Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1759, doi. 10.3390/cancers12071759
- By:
- Publication type:
- Article
Immunoglobulin M Paraproteinaemias.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1688, doi. 10.3390/cancers12061688
- By:
- Publication type:
- Article
STAT3: A Promising Therapeutic Target in Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 731, doi. 10.3390/cancers11050731
- By:
- Publication type:
- Article
The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies.
- Published in:
- Cancers, 2018, v. 10, n. 9, p. 327, doi. 10.3390/cancers10090327
- By:
- Publication type:
- Article
EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01606-6
- By:
- Publication type:
- Article
Chromatin interaction neural network (ChINN): a machine learning-based method for predicting chromatin interactions from DNA sequences.
- Published in:
- Genome Biology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s13059-021-02453-5
- By:
- Publication type:
- Article
Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 5, p. 190, doi. 10.1007/s11899-023-00704-9
- By:
- Publication type:
- Article
Regulation of hTERT by BCR-ABL at multiple levels in K562 cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip.
- Published in:
- NPJ Precision Oncology, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41698-019-0102-5
- By:
- Publication type:
- Article
Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00916-5
- By:
- Publication type:
- Article
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1261, doi. 10.3390/biom12091261
- By:
- Publication type:
- Article
3-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Prediction.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 8, p. 1093, doi. 10.3390/biom12081093
- By:
- Publication type:
- Article
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15608-y
- By:
- Publication type:
- Article
P-186: Toxicity and survival outcomes of autologous stem cell transplant in Multiple Myeloma patients with renal impairment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S139, doi. 10.1016/S2152-2650(21)02313-2
- By:
- Publication type:
- Article
P-098: Super-enhancer-driven PPP1R15B as an oncogenic and potential therapeutic target in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S92, doi. 10.1016/S2152-2650(21)02232-1
- By:
- Publication type:
- Article
MM-253: Single Cell Multi-Omic Analysis And Immune Cell Type Profiling Of Multiple Myeloma With t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S432, doi. 10.1016/S2152-2650(21)01963-7
- By:
- Publication type:
- Article
Poster: MM-253: Single Cell Multi-Omic Analysis And Immune Cell Type Profiling Of Multiple Myeloma With t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01602-5
- By:
- Publication type:
- Article
Bacterial Infection Among Patients With Multiple Myeloma Treated With Bortezomib-based Induction Therapy: Real-World Experience in an Asian Cancer Center.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Carfilzomib, Thalidomide and Dexamethasone (KTd) is safe and effective in RRMM: interim analysis of the single arm, multicentre phase II ALLG MM018/AMN002 study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e274, doi. 10.1016/j.clml.2019.09.452
- By:
- Publication type:
- Article
Salsalate is An Active Agent in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e135, doi. 10.1016/j.clml.2019.09.224
- By:
- Publication type:
- Article
Super-enhancer profiling of multiple myeloma in search of novel oncogenes and therapeutic targets.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e67, doi. 10.1016/j.clml.2019.09.106
- By:
- Publication type:
- Article
Validation of SKY92 high and low risk prognostication in a retrospective, multinational cohort of 155 non-trial multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e60, doi. 10.1016/j.clml.2019.09.094
- By:
- Publication type:
- Article
Synthetic lethality in multiple myeloma harboring double oncogenic hits of 17p13(del) and 1q21(amp).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e50, doi. 10.1016/j.clml.2019.09.077
- By:
- Publication type:
- Article
REIIBP is a histone methyltransferase overexpressed in T(4;14) multiple myeloma with oncogenic potential.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e20, doi. 10.1016/j.clml.2019.09.029
- By:
- Publication type:
- Article
Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Addressing Unmet Medical Needs in Maintenance Treatment for Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S248, doi. 10.1016/j.clml.2018.07.147
- By:
- Publication type:
- Article
Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction.
- Published in:
- 2018
- By:
- Publication type:
- journal article
REIIBP is a Histone Methyltransferase Overexpressed in T(4;14) Multiple Myeloma with Oncogenic Potential.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e53, doi. 10.1016/j.clml.2017.03.097
- By:
- Publication type:
- Article
Recurrent Chromosome Abnormalities Define Nonoverlapping Unique Subgroups of Tumors in Patients With Chronic Lymphocytic Leukemia and Known Karyotypic Abnormalities.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 467, doi. 10.1016/j.clml.2013.05.003
- By:
- Publication type:
- Article
Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0669-2
- By:
- Publication type:
- Article
Paraprotein interference in the diagnosis of hepatitis C infection.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Castleman's Disease Presenting as Prolonged Anemia and Growth Retardation: A Case Report and Literature Review.
- Published in:
- Acta Haematologica, 2011, v. 125, n. 3, p. 125, doi. 10.1159/000322119
- By:
- Publication type:
- Article
The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR).
- Published in:
- BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02227-0
- By:
- Publication type:
- Article
Recommendations to improve the clinical adoption of NGS‐based cancer diagnostics in Singapore.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 4, p. 222, doi. 10.1111/ajco.13339
- By:
- Publication type:
- Article
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00768-5
- By:
- Publication type:
- Article